WuXi Biologics
Offering End-to-End Solutions
WuXi XDC, a WuXi Biologics subsidiary, offers an unprecedented single-source approach for ADC development. This one-stop approach provides more efficiency, flexibility, lowered risks, fewer transactional costs, and our industry-leading 13 to 15-month DNA to IND timelines. We help you get into the clinic faster and obtain a competitive advantage.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?